The effect of Letrozole on clinical outcome in Progestin-Primed Ovarian Stimulation in women in normalovulatory women undergoing IVF cycle

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029169

Enrollment

Unknown

Registered

2020-01-17

Start date

2020-01-01

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Group A:A?

Group B:B?

Eligibility

Sex/Gender

Female

Age

18 Years to 39 Years

Inclusion criteria

Inclusion criteria: According to the WHO standards, the diagnosis of infertility; B-FSH less than 10IU/L; Aged younger than 40 years; Normal menstrual cycle24-35 days; Antral follicle counts more than 5; Did not receive any reproductive hormone drugs for nearly three months.

Exclusion criteria

Exclusion criteria: PCOS, endometrosis grade 3 or higher, documented ovarian failure, and any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

Measure	Time frame
the number of oocyte retrieved;LH value;HMG consumption per oocyte retrieval;	—

Secondary

Measure	Time frame
incidence of premeture LH;number of viable embryos;	—

Countries

China

Contacts

Public ContactKuang Yanping

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

kuangyanp@126.com+86 021-53078108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026